AR003134A1 - Uso de compuestos de 2-fenil-3-benzoil-benzotiofeno y de sales farmaceuticamente aceptables de los mismos para reducir el nivel de perdidasoseas, asociadas con la administracion de estrogenos. - Google Patents
Uso de compuestos de 2-fenil-3-benzoil-benzotiofeno y de sales farmaceuticamente aceptables de los mismos para reducir el nivel de perdidasoseas, asociadas con la administracion de estrogenos.Info
- Publication number
- AR003134A1 AR003134A1 ARP960102930A AR10293096A AR003134A1 AR 003134 A1 AR003134 A1 AR 003134A1 AR P960102930 A ARP960102930 A AR P960102930A AR 10293096 A AR10293096 A AR 10293096A AR 003134 A1 AR003134 A1 AR 003134A1
- Authority
- AR
- Argentina
- Prior art keywords
- pharmaceutically acceptable
- compounds
- phenyl
- acceptable salts
- benzotiophene
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 229940011871 estrogen Drugs 0.000 title 1
- 239000000262 estrogen Substances 0.000 title 1
- -1 methyl-1-pyrrolidinyl Chemical group 0.000 abstract 3
- 150000003839 salts Chemical class 0.000 abstract 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
- 125000004214 1-pyrrolidinyl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 abstract 1
- 206010065687 Bone loss Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 abstract 1
- XSXHWVKGUXMUQE-UHFFFAOYSA-N osmium dioxide Inorganic materials O=[Os]=O XSXHWVKGUXMUQE-UHFFFAOYSA-N 0.000 abstract 1
- KCYXFWVKLKHLHF-UHFFFAOYSA-N phenyl-(2-phenyl-1-benzothiophen-3-yl)methanone Chemical class C=1C=CC=CC=1C(=O)C(C1=CC=CC=C1S1)=C1C1=CC=CC=C1 KCYXFWVKLKHLHF-UHFFFAOYSA-N 0.000 abstract 1
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
Uso de los compuestos de 2-fenil-3-benzoil benzotiofeno de la fórmula (II) donde R1 es independientemente -H, -OH, -O(C1-4 alquilo), -OCO-alquilo -OCOC6H5ó -OSO2 (C4-C6 alquilo); y R2 es 1-piperidinilo, 1-pirrolidinilo, metil-1- pirrolidinilo,dimetil-1-pirrolidinilo, 4-morfolino, dimetilamino, dietilaminoo hexametilenoimino y sales farmacéuticamente aceptables de los mismos, caracterizado porque comprende la preparación de medicamentos útiles parareducir al mínimo los efectos del a pérdida ósea cuando se administran compuestos de fórmula (I) donde R es -CH2CON(CH3)-n-CH2-CH2CH2CH3 ó -SO(CH2)3CF2CF3, ó una sal farmacéuticamente aceptable del mismo.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US47111195A | 1995-06-06 | 1995-06-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR003134A1 true AR003134A1 (es) | 1998-07-08 |
Family
ID=23870302
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP960102930A AR003134A1 (es) | 1995-06-06 | 1996-06-05 | Uso de compuestos de 2-fenil-3-benzoil-benzotiofeno y de sales farmaceuticamente aceptables de los mismos para reducir el nivel de perdidasoseas, asociadas con la administracion de estrogenos. |
| ARP960102931A AR003002A1 (es) | 1995-06-06 | 1996-06-05 | Composiciones farmaceuticas para reducir las perdidas oseas cuando se administran esteroides y metodo para reducir dichas perdidas aplicando dichascomposiciones |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP960102931A AR003002A1 (es) | 1995-06-06 | 1996-06-05 | Composiciones farmaceuticas para reducir las perdidas oseas cuando se administran esteroides y metodo para reducir dichas perdidas aplicando dichascomposiciones |
Country Status (27)
| Country | Link |
|---|---|
| EP (1) | EP0747056B1 (es) |
| JP (1) | JP2001501907A (es) |
| KR (1) | KR19990022497A (es) |
| CN (1) | CN1239429A (es) |
| AR (2) | AR003134A1 (es) |
| AT (1) | ATE187643T1 (es) |
| AU (1) | AU696927B2 (es) |
| BR (1) | BR9608390A (es) |
| CA (1) | CA2223174A1 (es) |
| CO (1) | CO4700447A1 (es) |
| CZ (1) | CZ383097A3 (es) |
| DE (1) | DE69605600T2 (es) |
| DK (1) | DK0747056T3 (es) |
| EA (1) | EA199800014A1 (es) |
| ES (1) | ES2142545T3 (es) |
| GR (1) | GR3032863T3 (es) |
| HU (1) | HUP9900854A3 (es) |
| IL (1) | IL118573A (es) |
| NO (1) | NO975560L (es) |
| PE (1) | PE2298A1 (es) |
| PL (1) | PL323941A1 (es) |
| PT (1) | PT747056E (es) |
| SI (1) | SI0747056T1 (es) |
| TR (1) | TR199701508T1 (es) |
| WO (1) | WO1996039141A1 (es) |
| YU (1) | YU34296A (es) |
| ZA (1) | ZA964681B (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0937145A1 (en) * | 1996-11-22 | 1999-08-25 | Akzo Nobel N.V. | Bmp-4 promoter and use thereof in screening of therapeutic agents for the prevention and/or treatment of osteoporosis |
| GB2324726A (en) * | 1997-05-01 | 1998-11-04 | Merck & Co Inc | Combination Therapy for the Treatment of Osteoporosis |
| US6096764A (en) * | 1997-08-21 | 2000-08-01 | Eli Lilly And Company | Methods for inhibiting detrimental side-effects due to GnRH of GnRH agonist administration |
| US6465445B1 (en) * | 1998-06-11 | 2002-10-15 | Endorecherche, Inc. | Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| US7005428B1 (en) | 1998-06-11 | 2006-02-28 | Endorecherche, Inc. | Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4895715A (en) * | 1988-04-14 | 1990-01-23 | Schering Corporation | Method of treating gynecomastia |
| US5393785A (en) * | 1988-10-31 | 1995-02-28 | Endorecherche, Inc. | Therapeutic antiestrogens |
| US5482949A (en) * | 1993-03-19 | 1996-01-09 | Eli Lilly And Company | Sulfonate derivatives of 3-aroylbenzo[b]thiophenes |
| DE4329344A1 (de) * | 1993-08-27 | 1995-03-02 | Schering Ag | Progesteronantagonistisch- und antiöstrogen wirksame Verbindungen für die Behandlung des Leiomyomata uteri |
-
1996
- 1996-05-30 DE DE69605600T patent/DE69605600T2/de not_active Expired - Fee Related
- 1996-05-30 AT AT96303874T patent/ATE187643T1/de not_active IP Right Cessation
- 1996-05-30 EP EP96303874A patent/EP0747056B1/en not_active Expired - Lifetime
- 1996-05-30 SI SI9630163T patent/SI0747056T1/xx unknown
- 1996-05-30 DK DK96303874T patent/DK0747056T3/da active
- 1996-05-30 PT PT96303874T patent/PT747056E/pt unknown
- 1996-05-30 ES ES96303874T patent/ES2142545T3/es not_active Expired - Lifetime
- 1996-06-05 PL PL96323941A patent/PL323941A1/xx unknown
- 1996-06-05 AR ARP960102930A patent/AR003134A1/es not_active Application Discontinuation
- 1996-06-05 WO PCT/US1996/008810 patent/WO1996039141A1/en not_active Ceased
- 1996-06-05 BR BR9608390A patent/BR9608390A/pt not_active Application Discontinuation
- 1996-06-05 CN CN96195984A patent/CN1239429A/zh active Pending
- 1996-06-05 HU HU9900854A patent/HUP9900854A3/hu unknown
- 1996-06-05 CO CO96029179A patent/CO4700447A1/es unknown
- 1996-06-05 JP JP09501298A patent/JP2001501907A/ja active Pending
- 1996-06-05 CZ CZ973830A patent/CZ383097A3/cs unknown
- 1996-06-05 AR ARP960102931A patent/AR003002A1/es not_active Application Discontinuation
- 1996-06-05 AU AU59816/96A patent/AU696927B2/en not_active Ceased
- 1996-06-05 ZA ZA9604681A patent/ZA964681B/xx unknown
- 1996-06-05 PE PE1996000409A patent/PE2298A1/es not_active Application Discontinuation
- 1996-06-05 YU YU34296A patent/YU34296A/sr unknown
- 1996-06-05 IL IL11857396A patent/IL118573A/xx not_active IP Right Cessation
- 1996-06-05 TR TR97/01508T patent/TR199701508T1/xx unknown
- 1996-06-05 EA EA199800014A patent/EA199800014A1/ru unknown
- 1996-06-05 CA CA002223174A patent/CA2223174A1/en not_active Abandoned
- 1996-06-05 KR KR1019970708978A patent/KR19990022497A/ko not_active Withdrawn
-
1997
- 1997-12-02 NO NO975560A patent/NO975560L/no unknown
-
2000
- 2000-03-03 GR GR20000400555T patent/GR3032863T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR9608390A (pt) | 1999-05-04 |
| HUP9900854A2 (hu) | 1999-08-30 |
| PE2298A1 (es) | 1998-02-28 |
| HUP9900854A3 (en) | 2000-03-28 |
| GR3032863T3 (en) | 2000-07-31 |
| EA199800014A1 (ru) | 1998-06-25 |
| YU34296A (en) | 1999-11-22 |
| JP2001501907A (ja) | 2001-02-13 |
| CZ383097A3 (cs) | 1998-09-16 |
| NO975560D0 (no) | 1997-12-02 |
| TR199701508T1 (xx) | 1998-03-21 |
| AU696927B2 (en) | 1998-09-24 |
| CA2223174A1 (en) | 1996-12-12 |
| EP0747056A2 (en) | 1996-12-11 |
| DK0747056T3 (da) | 2000-05-01 |
| EP0747056B1 (en) | 1999-12-15 |
| DE69605600T2 (de) | 2000-05-31 |
| KR19990022497A (ko) | 1999-03-25 |
| CN1239429A (zh) | 1999-12-22 |
| AR003002A1 (es) | 1998-05-27 |
| DE69605600D1 (de) | 2000-01-20 |
| PT747056E (pt) | 2000-05-31 |
| EP0747056A3 (en) | 1997-03-05 |
| WO1996039141A1 (en) | 1996-12-12 |
| CO4700447A1 (es) | 1998-12-29 |
| IL118573A0 (en) | 1996-10-16 |
| ZA964681B (en) | 1997-12-05 |
| ATE187643T1 (de) | 2000-01-15 |
| NO975560L (no) | 1998-01-26 |
| SI0747056T1 (en) | 2000-06-30 |
| PL323941A1 (en) | 1998-04-27 |
| IL118573A (en) | 2000-01-31 |
| AU5981696A (en) | 1996-12-24 |
| ES2142545T3 (es) | 2000-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60039125D1 (de) | 9-(piperazinylalkyl)carbazole als bax-modulatoren | |
| AR015987A1 (es) | DERIVADOS DE PLEUROMUTILINA, COMPOSICIoN FARMACÉUTICA QUE LOS CONTIENE, Y, SU USO PARA LA ELABORACIoN DE UN MEDICAMENTO. | |
| ES2150577T3 (es) | Aminoeteres aromaticos como agentes para aliviar el dolor. | |
| ES2141957T3 (es) | Uso de raloxifeno y sus analogos para la produccion de un medicamento para el tratamiento de enfermedades virales. | |
| MX9300786A (es) | Compuestos hipolipidaemicos. | |
| UY26258A1 (es) | Derivados de 8-fenil-6,9-dihidro-[1,2,4] triazolo [3,4-i] purin-5-ona. | |
| DK0562956T3 (da) | Hidtil ukendte naphthylalkylaminer, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem | |
| AR024145A1 (es) | Derivados de 5-fenil-pirimidina | |
| AR019053A1 (es) | Uso de 2'2'-difluoronucleosidos para la preparacion de un medicamento y composicion farmaceutica y producto farmaceutico que los contienen | |
| ES2118203T3 (es) | Nuevos derivados benzopiranicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen. | |
| DE3069813D1 (en) | Pharmaceutical composition containing a diphenylhydantoin derivative, derivatives used and their preparation | |
| CO4700446A1 (es) | Procedimientos para minimizar la perdida osea | |
| YU42397A (sh) | Korišćenje raloksifena za pripremu leka | |
| ES2108240T3 (es) | Derivados de tiosemicarbazona de 2-formilpiridina, su preparacion y su uso como agentes antitumor. | |
| AR022839A1 (es) | Antagonistas de la integrina alfavbeta3 en combinacion con agentes quimioterapeuticos | |
| AR003134A1 (es) | Uso de compuestos de 2-fenil-3-benzoil-benzotiofeno y de sales farmaceuticamente aceptables de los mismos para reducir el nivel de perdidasoseas, asociadas con la administracion de estrogenos. | |
| ES2091126T3 (es) | Nuevos compuestos biciclicos de pirimidina, su procedimiento de preparacion y composiciones farmaceuticas que los contienen. | |
| AR004691A1 (es) | Nuevos derivados de [3-alcoxi-fenoxi-)-etil]-dialquilamina, una composicion farmaceutica que los comprende, su uso como anestesicos locales y unprocedimiento para su preparacion | |
| KR960034200A (ko) | 항편두통성 인돌릴알킬-피리딘일 및 피리미딘일피페라진의 1,2,5-티아디아졸 유도체 | |
| ES2078838A1 (es) | Procedimiento para preparar una composicion a base de clozapina. | |
| FI953566A0 (fi) | Tahdospironia tai sen analogeja sisältäviä koostumuksia | |
| ES2128701T3 (es) | Derivados triciclicos y su uso en productos farmaceuticos. | |
| KR960703912A (ko) | 중추신경계 활성을 갖는 헤테로사이클 아민(heterocyclic amines having central nervous system activity) | |
| DE69300296D1 (de) | Thiochromanderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen. | |
| KR900012925A (ko) | 인돌 유도체 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |